UPDATE: Feds demand Armstrong medical records from IU
The government wants to see Lance Armstrong’s medical records from his treatments for cancer as it attempts to recover millions of dollars in sponsorship money paid to his cycling teams.
Health Care & Life Sciences
Articles
Lilly accused at trial of hiding Cymbalta ‘brain zap’ risk
The drugmaker faces as many as 5,000 cases claiming it downplayed Cymbalta’s withdrawal risks, which allegedly include electrical-shock sensations, vomiting and insomnia.
Indiana medical software company hack affected 3.9M people
The company said the exposed information includes names, addresses, birthdates, Social Security numbers and health records.
After revenue rebounds, Hoosier hospitals start hiring again
Hospitals around Indiana have added 2,400 jobs since September as profits, patient visits and insurance coverage all improved.
Anthem’s Indiana profits soar as Hoosiers cut medical spending by $1 billion
Anthem turned out unheard of gains in 2014, the first year of Obamacare’s new health insurance overhaul, as Anthem’s customers numbers held steady but their spending with hospitals and doctors plummeted.
Tech firm to sponsor free rides for downtown bikeshare
Pedestrians in downtown Indy this weekend can become bicyclists for no charge, as a global technology firm sponsors free rides through the Indiana Pacers Bikeshare program.
Anthem’s second-quarter profit surges past analyst expectations
Indianapolis-based Anthem Inc. reported Wednesday morning that it earned $859.1 million during the three months ended June 30, an increase of 17.5 percent over the same quarter of 2014.
Health spending to gobble up more of U.S. economy
Payments for hospitals, doctors, drugs and insurance will rise by about 5.8 percent a year through 2024—1.1 percentage points faster than overall economic growth, actuaries at the Centers for Medicare and Medicaid Services said Tuesday in an annual study.
Anthem gets $26.5B funding commitment for Cigna takeover
Anthem Inc.’s bid to become the largest health insurer in history is setting up one of the biggest debt offerings backing a takeover.
Lilly expands R&D outside Indy—again
State and city leaders spend millions each year to entice companies to move here and add jobs here. But for the second time in three months, Eli Lilly and Co. has shown that the biggest attraction to a company is talented workers.
Health insurer deal fever may spread to hospitals next
Seeing mergers like Anthem’s planned acquisition of Cigna Corp., hospitals could decide that striking deals of their own could improve their negotiating power over medical reimbursements.
City dodges bullet as HQ stays under Anthem-Cigna deal
The company says its corporate headquarters will remain in Indianapolis, where its operations are responsible for contributing millions of dollars in corporate taxes and charitable giving.
VA secretary optimistic Congress will plug budget gap
During a visit to the Richard L. Roudebush VA Medical Center in Indianapolis, Robert McDonald said Thursday he thinks Congress will act to avoid shutting down some VA hospitals and other cost-cutting steps.
FROM THE ARCHIVES: Anthem’s path from laggard to leader
This 1992 profile of then-CEO L. Ben Lytle chronicles the evolution of the company—then known as The Associated Group—from a sleepy health insurer operating in only one state into an acquisitive, aggressive business with national ambitions.
Anthem to buy Cigna in $54B deal
After a long and stormy courtship, Anthem Inc. announced Friday morning that it will pay $188 per share to acquire Cigna Corp., valuing the deal at $54.2 billion in cash, stock and the assumption of debt.
Lilly, Anthem show high risk, high reward strategy can pay off
The CEOs of Eli Lilly and Anthem are being rewarded by investors for taking high-risk approaches to develop breakthrough drugs, make major acquisitions.
Investors still cautious about antitrust scrutiny on Anthem-Cigna deal
The stock price for Cigna Corp. remained lethargic during trading Thursday, as another mega-merger of insurers complicated the Anthem deal and sparked antitrust concerns.
Lilly posts lackluster profit but boosts full-year forecast
Eli Lilly and Co.’s profits plunged 18 percent in the second-quarter but still easily beat the lowered expectations of Wall Street analysts.
Alzheimer’s trials offer little certainty for investors, patients
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
Indy-area woman charged with faking nursing license, cancer
Ashley Trent faces charges of forgery, deception, theft and practicing nursing without a license. She also is accused of forging letters from IU Health that claimed she had breast cancer.